Florida Cancer Specialists & Research Institute Expands Specialized Gynecologic Oncology Services

Marcia Schmidt, MD Joins Statewide Practice in Palm Beach County

FORT MYERS, Fla., Sept. 29, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome board-certified gynecologic oncologist Marcia Schmidt, MD to its team of cancer experts in Palm Beach County. She is providing specialized care to women with gynecologic and breast cancers at FCS locations in Delray Beach,  5130 Linton Blvd., Ste. B4, Delray Beach, FL 33484 and Good Samaritan Flagler, 1309 N. Flagler Dr., West Palm Beach, FL 33401.

FCS Medical Director of Gynecologic Oncology Jessica Stine, MD said,  "With advanced specialized training in gynecologic oncology, breast health, minimally-invasive surgery, and genetic cancer risk assessment, Dr. Schmidt exemplifies the highest standards of expertise and skill in women's cancer care."

"FCS is proud to enhance access to specialized care with the addition of a seventh gynecologic oncologist to our statewide practice," said David Wenk, MD, FCS assistant managing physician. "Patients in Palm Beach County will benefit greatly from Dr. Schmidt's depth of experience and her comprehensive, compassionate approach to each patient's unique needs."

After completing medical school at Upstate Medical University at the State University of New York in Syracuse and a residency obstetrics and gynecology at Winthrop University Hospital,  Dr. Schmidt was awarded fellowships in pelvic surgery at Emory University School of Medicine in Atlanta, in gynecologic oncology at the University of South Florida Moffit Cancer Center in Tampa, and in breast surgery at Brown University Women and Infants Hospital in Providence, Rhode Island. She has completed an intensive course in genetic cancer risk assessment through the City of Hope Clinical Cancer Genomics Division.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

For More Information, Contact:
FCS Media Relations
(239) 675-7201

Michelle Robey, Vice President of Marketing
[email protected]

Jen Bradley, Senior Director of Corporate Communications
[email protected]

SOURCE Florida Cancer Specialists & Research Institute